These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25267383)

  • 21. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Source terms and attenuation lengths for estimating shielding requirements or dose analyses of proton therapy accelerators.
    Sheu RJ; Lai BL; Lin UT; Jiang SH
    Health Phys; 2013 Aug; 105(2):128-39. PubMed ID: 23799497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams.
    Polf JC; Newhauser WD
    Phys Med Biol; 2005 Aug; 50(16):3859-73. PubMed ID: 16077232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monte Carlo simulations for the shielding of the future high-intensity accelerator facility FAIR at GSI.
    Radon T; Gutermuth F; Fehrenbacher G
    Radiat Prot Dosimetry; 2005; 115(1-4):212-5. PubMed ID: 16381714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laser electron accelerators for radiation medicine: a feasibility study.
    Chiu C; Fomytskyi M; Grigsby F; Raischel F; Downer MC; Tajima T
    Med Phys; 2004 Jul; 31(7):2042-52. PubMed ID: 15305457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monte Carlo estimation of photoneutrons contamination from high-energy X-ray medical accelerators in treatment room and maze: a simplified model.
    Zabihzadeh M; Ay MR; Allahverdi M; Mesbahi A; Mahdavi SR; Shahriari M
    Radiat Prot Dosimetry; 2009 Jul; 135(1):21-32. PubMed ID: 19483207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric considerations on TEPC fluka-simulation and measurements.
    Rollet S; Beck P; Ferrari A; Pelliccioni M; Autischer M
    Radiat Prot Dosimetry; 2004; 110(1-4):833-7. PubMed ID: 15353755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shielding analysis of proton therapy accelerators: a demonstration using Monte Carlo-generated source terms and attenuation lengths.
    Lai BL; Sheu RJ; Lin UT
    Health Phys; 2015 May; 108(2 Suppl 2):S84-93. PubMed ID: 25811254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental Set-up for FLASH Proton Irradiation of Small Animals Using a Clinical System.
    Patriarca A; Fouillade C; Auger M; Martin F; Pouzoulet F; Nauraye C; Heinrich S; Favaudon V; Meyroneinc S; Dendale R; Mazal A; Poortmans P; Verrelle P; De Marzi L
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):619-626. PubMed ID: 30017793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doses to patients from photoneutrons emitted in a medical linear accelerator.
    Saeed MK; Moustafa O; Yasin OA; Tuniz C; Habbani FI
    Radiat Prot Dosimetry; 2009 Feb; 133(3):130-5. PubMed ID: 19287045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shielding of proton accelerators.
    Agosteo S; Magistris M; Silari M
    Radiat Prot Dosimetry; 2011 Jul; 146(4):414-24. PubMed ID: 21672935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimum design of a moderator system based on dose calculation for an accelerator driven Boron Neutron Capture Therapy.
    Inoue R; Hiraga F; Kiyanagi Y
    Appl Radiat Isot; 2014 Jun; 88():225-8. PubMed ID: 24440538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutron H*(10) inside a proton therapy facility: comparison between Monte Carlo simulations and WENDI-2 measurements.
    De Smet V; Stichelbaut F; Vanaudenhove T; Mathot G; De Lentdecker G; Dubus A; Pauly N; Gerardy I
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):417-21. PubMed ID: 24255173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a flattening filter free linear accelerator on structural shielding design.
    Jank J; Kragl G; Georg D
    Z Med Phys; 2014 Mar; 24(1):38-48. PubMed ID: 23763984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study.
    Bues M; Newhauser WD; Titt U; Smith AR
    Radiat Prot Dosimetry; 2005; 115(1-4):164-9. PubMed ID: 16381706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary shielding assessment for the 100 MeV proton linac (KOMAC).
    Lee YO; Cho YS; Chang J
    Radiat Prot Dosimetry; 2005; 115(1-4):569-72. PubMed ID: 16381787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation protection modelling for 2.5 Petawatt-laser production of ultrashort x-ray, proton and ion bunches: Monte Carlo model of the Munich CALA facility.
    Englbrecht FS; Döpp A; Hartmann J; Lindner FH; Groß ML; Wirth HF; Thirolf PG; Karsch S; Schreiber J; Parodi K; Dedes G
    J Radiol Prot; 2020 Sep; 40(4):. PubMed ID: 32702682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monte Carlo simulations for the design of the treatment rooms and synchrotron access mazes in the CNAO Hadrontherapy facility.
    Porta A; Agosteo S; Campi F
    Radiat Prot Dosimetry; 2005; 113(3):266-74. PubMed ID: 15713741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation shielding design of a new tomotherapy facility.
    Zacarias A; Balog J; Mills M
    Health Phys; 2006 Oct; 91(4):289-95. PubMed ID: 16966872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation protection aspects of a 4 MW target.
    Agosteo S; Magistris M; Silari M
    Radiat Prot Dosimetry; 2005; 115(1-4):465-9. PubMed ID: 16381768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.